Medicxi Ventures Management (Jersey) Ltd
SEC Form 4 insider trading activity
Medicxi Ventures Management (Jersey) Ltd has filed 1 SEC Form 4 filing (6 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jun 24, 2026.
On the most recent filing, Medicxi Ventures Management (Jersey) Ltd is listed as 10% Owner at Centessa Pharmaceuticals plc. Inside the rolling window, Medicxi Ventures Management (Jersey) Ltd reported no open-market purchases and 1 open-market sale in CNTA.
Companies traded
Other insiders at CNTA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Medicxi Ventures Management (Jersey) Ltd made?
Medicxi Ventures Management (Jersey) Ltd has filed 1 SEC Form 4 filing (6 transaction rows) across 1 company since 2026.
Which companies does Medicxi Ventures Management (Jersey) Ltd trade?
Medicxi Ventures Management (Jersey) Ltd has filed SEC Form 4 disclosures for 1 company, including CNTA.
When was Medicxi Ventures Management (Jersey) Ltd's most recent SEC Form 4 filing?
Medicxi Ventures Management (Jersey) Ltd's most recent SEC Form 4 filing on Tracefour is dated Jun 24, 2026.